Replimune Group Statistics
Total Valuation
Replimune Group has a market cap or net worth of $1.50 billion. The enterprise value is $1.41 billion.
| Market Cap | 1.50B |
| Enterprise Value | 1.41B |
Important Dates
The last earnings date was Friday, August 14, 2026, before market open.
| Earnings Date | Aug 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Replimune Group has 94.22 million shares outstanding. The number of shares has increased by 20.99% in one year.
| Current Share Class | 94.22M |
| Shares Outstanding | 94.22M |
| Shares Change (YoY) | +20.99% |
| Shares Change (QoQ) | +1.33% |
| Owned by Insiders (%) | 1.59% |
| Owned by Institutions (%) | 77.32% |
| Float | 67.65M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 20.06 |
| PB Ratio | 12.62 |
| P/TBV Ratio | 14.16 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.23, with a Debt / Equity ratio of 1.06.
| Current Ratio | 5.23 |
| Quick Ratio | 5.09 |
| Debt / Equity | 1.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -29.78 |
Financial Efficiency
Return on equity (ROE) is -134.29% and return on invested capital (ROIC) is -58.72%.
| Return on Equity (ROE) | -134.29% |
| Return on Assets (ROA) | -51.30% |
| Return on Invested Capital (ROIC) | -58.72% |
| Return on Capital Employed (ROCE) | -138.42% |
| Weighted Average Cost of Capital (WACC) | 9.05% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$638,738 |
| Employee Count | 465 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -551,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +189.25% in the last 52 weeks. The beta is 0.90, so Replimune Group's price volatility has been lower than the market average.
| Beta (5Y) | 0.90 |
| 52-Week Price Change | +189.25% |
| 50-Day Moving Average | 11.63 |
| 200-Day Moving Average | 8.38 |
| Relative Strength Index (RSI) | 65.08 |
| Average Volume (20 Days) | 6,769,597 |
Short Selling Information
The latest short interest is 27.54 million, so 29.23% of the outstanding shares have been sold short.
| Short Interest | 27.54M |
| Short Previous Month | 23.65M |
| Short % of Shares Out | 29.23% |
| Short % of Float | 40.71% |
| Short Ratio (days to cover) | 4.70 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -296.26M |
| Pretax Income | -297.56M |
| Net Income | -297.01M |
| EBITDA | -290.44M |
| EBIT | -296.26M |
| Earnings Per Share (EPS) | -$3.15 |
Balance Sheet
The company has $195.33 million in cash and $111.98 million in debt, with a net cash position of $83.35 million or $0.88 per share.
| Cash & Cash Equivalents | 195.33M |
| Total Debt | 111.98M |
| Net Cash | 83.35M |
| Net Cash Per Share | $0.88 |
| Equity (Book Value) | 105.65M |
| Book Value Per Share | 1.26 |
| Working Capital | 162.40M |
Cash Flow
In the last 12 months, operating cash flow was -$279.06 million and capital expenditures -$1.49 million, giving a free cash flow of -$280.55 million.
| Operating Cash Flow | -279.06M |
| Capital Expenditures | -1.49M |
| Depreciation & Amortization | 5.82M |
| Net Borrowing | 34.23M |
| Free Cash Flow | -280.55M |
| FCF Per Share | -$2.98 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Replimune Group does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -20.99% |
| Shareholder Yield | -20.99% |
| Earnings Yield | -19.85% |
| FCF Yield | -18.75% |
Analyst Forecast
The average price target for Replimune Group is $19.50, which is 22.80% higher than the current price. The consensus rating is "Buy".
| Price Target | $19.50 |
| Price Target Difference | 22.80% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |